Benefit Risk Assessment

When planning for a phase III clinical trial, the insights gained by BAST’s modelling and simulation work will allow our clients to select a dosing schedule that optimally balances the trade-offs between the benefits and risks of the new drug.

Contact us for more information or a quote, if you think that our services will be of help to you!